ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1276

Improvement in Work and Household Productivity for Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with Anti-TNFs in Routine Clinical Practice in Turkey

Sebnem Ataman1, Mehmet Kirnap2, Buminhan Seferoglu3, Zuhal Altay4, Aylin Rezvani5, Omer Kuru6,7, Erhan Capkin8, Nazli Derya Bugdayci9, Ilhan Sezer10, Hasan Fatih CAY11 and Akinci Tan12, 1Rheumatology Department, Ankara University Faculty of Medicine, Ankara, Turkey, 2Department of Physical Medicine and Rehabilitation, Erciyes University, Kayseri, Turkey, 3Physical Medicine and Rehabilitation, Ataturk University Medical School, Erzurum, Turkey, 4ELAZIG KARAYOLU UZERI, Inonu University, Turgut Ozal Medical Center, Malatya, Turkey, 5Department of Physical Medicine and Rehabilitation, Bezmialem Foundation University, İstanbul, Turkey, 6Kurupelit Mevkii Kurupelit 552, Ondokuz Mayis Univ.Tip Fak.Has.-Fizik Tedavi, Samsun, Turkey, 7Physical Medicine and Rehabilitation, Ondokuz Mayis University, Samsun, Turkey, 8PM&R AND RHEUMATOLOGY, Karadeniz Tecnical University, Faculty of Medicine, TRABZON, Turkey, 9Physical Treatment and Rehabilitation, Istanbul Physical Treatment and Rehabilitation Training and Research Hospital, Istanbul, Turkey, 10Rheumatology, Physical Medicine and Rheabilitation, Antalya Education and Research Hospital, Antalya, Turkey, 11Rheumatology, Physical Medicine&Rehabilitation, Antalya Education and Research Hospital, Antalya, Turkey, 12Physical Med & Rehab, Hacettepe Univ, Ankara, Turkey

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Ankylosing spondylitis (AS), anti-TNF therapy, Clinical practice, Rheumatoid arthritis (RA) and work

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Health Services Research Poster II (ACR): Healthcare Access, Patterns of Medication Use and Workforce Considerations

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

The impact of  rheumatoid arthritis (RA) and ankylosing spondylitis (AS)  on paid work is measured on the basis of employed people missing time from work (absenteeism)  and reduced performance while at work (presenteeism) which leads to reduced routine working hours through changing or even losing jobs (employment status change). Work loss due to disabling rheumatic conditions is an important medical and social issue and various epidemiological studies explored the impact on the productivity, but there are few studies conducted in Turkey. We planned a non-interventional study on the basis of geo-demographic representation and explored the effects of treatment.

Methods:

In this study work disability and productivity loss was investigated through collecting data on worked hours per week and lost hours per week for paid work and household activity in RA and AS patients treated with anti-TNFs. Work and household productivity was also measured with Work Productivity and Activity Impairment Index (WPAI) scores.  A total of 713 patients who were >18 years of age and with proven diagnosis of AS or RA in accordance with ACR and Modified New York Criteria were analysed. Additional parameters of quality of life (QoL) measurements by SF-36 (RA and AS), ASQoL (AS); disease scores by DAS-28 (RA) and BASDAI (AS) and functional assessments by HAQ-DI (RA), BASFI (AS) were evaluated.

Results:

A total of 713 patients enrolled (481 AS, 232 RA patients) where AS patients were younger compared to RA patients (37.6 + 10.0 versus 48.7 + 11.7 years, ns). Absenteeism decreased (14.1 hours to 3.3 hours for RA, 18.9 hours to 6.4 hours for AS patients) during 15 months follow-up  and presenteeism increased towards the end of the study (p<0.001). WPAI evaluations also revealed significant decreases in four assessed parameters for RA and AS (p<0.001) except for missed hours in AS patients (p=0.006). During follow-up, both RA and AS patients experienced major and significant improvements in their health and quality of life with anti-TNF treatment combined with DMARDs and with or without NSAIDs. Disease activity scores of DAS-28 and BASDAI were significantly improved (p<0.001). Health related information by means of patient reported outcomes (SF-36 for AS and RA, ASQoL for AS, and HAQ-DI for RA) showed significant improvements in all parameters for both group of patients at 15 months (p<0.001). Disease related functional assessment were evaluated by means of BASFI in AS patients and improvements in all functional disability categories were reported (p<0.001). Treatments were well tolerated, cessation of anti-TNF treatment due to adverse events were infrequent (3.0% in AS and 1.6% in RA patients).

Conclusion:

In this study we have shown that overall work loss was significantly reduced with anti-TNF treatment during the follow-up period along with improvements in disease activity scores, QoL surveys and in disease related functional assessment outcomes.


Disclosure: S. Ataman, Roche Pharmaceuticals, 5,Pfizer Inc, 5,UCB, 5,Mustafa Nevzat, 5,BMS, 5,MSD, 5; M. Kirnap, BMS, 8,Pfizer Inc, 8,MSD, 8; B. Seferoglu, None; Z. Altay, None; A. Rezvani, MSD, 8; O. Kuru, Abbvie, 8,Roche Pharmaceuticals, 8,Pfizer Inc, 8,MSD, 8,BMS, 8,UCB, 8,Amgen, 8; E. Capkin, Abbvie, 8; N. D. Bugdayci, MSD, 5; I. Sezer, Abbvie, 8; H. F. CAY, Roche Pharmaceuticals, 8,MSD, 8; A. Tan, Pfizer Inc, 8,Abbvie, 8,MSD, 8,Nobel, 8,Lilly, 8,BMS, 8.

To cite this abstract in AMA style:

Ataman S, Kirnap M, Seferoglu B, Altay Z, Rezvani A, Kuru O, Capkin E, Bugdayci ND, Sezer I, CAY HF, Tan A. Improvement in Work and Household Productivity for Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with Anti-TNFs in Routine Clinical Practice in Turkey [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/improvement-in-work-and-household-productivity-for-patients-with-rheumatoid-arthritis-and-ankylosing-spondylitis-treated-with-anti-tnfs-in-routine-clinical-practice-in-turkey/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/improvement-in-work-and-household-productivity-for-patients-with-rheumatoid-arthritis-and-ankylosing-spondylitis-treated-with-anti-tnfs-in-routine-clinical-practice-in-turkey/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology